ELIZABETH BERRY: Open Payments
NPI 1427834860 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 23 payments from 6 companies in 2025. Trend: 2023 $373 · 2024 $748 · 2025 $522
Food & beverage: $495Education: $27
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $135 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ABBVIE INC. | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: CAPLYTA, TRINTELLIX, REXULTI, VRAYLAR, COBENFY, HETLIOZ.
Industry payments across SC — which companies pay providers there.
